The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes

For diabetes, with many costly noncommunicable diseases already explicitly modelled as complications, and with many interventions having predominantly an effect on the improvement of quality of life, unrelated future medical costs have a small impact on the outcomes of health economic evaluations.

Authors

Institutions

Publication Details

Journal
Applied Health Economics and Health Policy
Published
2024-09-16
DOI
https://doi.org/10.1007/s40258-024-00914-z
Citations
2
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
2.26

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes

Talitha Feenstra, Andreas Nilsson, V. Foos, James Altunkaya et al.
2 citations
Applied Health Economics and Health Policy
Health Systems, Economic Evaluations, Quality of Life
2.26
article

The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes

Talitha Feenstra, Andreas Nilsson, V. Foos, James Altunkaya, Michelle Tew, Neda Laiteerapong, Andrew John Palmer, Mark Lamotte, Samuel J. P. Malkin, Pieter van Baal, William J. Valentine, Jianchao Quan, Michael Willis, Elbert S. Huang, José Leal, Philip Clarke, Barnaby Hunt, Richard Fulton Pollock, Phil C. McEwan, Mafalda Ramos, An Tran‐Duy, Ting Zhao, Luís Dias Martins, Harry J. Smolen
article en
2 citations

Abstract

For diabetes, with many costly noncommunicable diseases already explicitly modelled as complications, and with many interventions having predominantly an effect on the improvement of quality of life, unrelated future medical costs have a small impact on the outcomes of health economic evaluations.

Applied Health Economics and Health PolicyVol. 22(6)
University of Tasmania (AU), The University of Melbourne (AU), University of Groningen (NL), University of Oxford (GB), University of Chicago (US), National Institute for Public Health and the Environment (NL), Medical Decision Modeling (United States) (US), Swedish Institute for Health Economics (SE), Health Economics and Outcomes Research (United Kingdom) (GB), HKU-Pasteur Research Pole (HK), A-T Society (GB), Covalence Research, University of Hong Kong (HK), Erasmus University Rotterdam (NL)
University of Tasmania
Openalex Percentile: Top 8%
Health Systems, Economic Evaluations, Quality of Life
2.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.